Signing an MoU between JFDA and AmCham-Jordan and PhRMA LAWG

The American Chamber of Commerce in Jordan (AmCham-Jordan) in its capacity as representative of Local Area Working Group-Jordan comprised of the Leading Innovative Bio-pharmaceutical Research Companies (LAWG PhRMA) and The Jordan Food and Drug Administration (JFDA) agreed to build cooperation by signing a Memorandum of Understanding (MoU) on “Improving Jordan’s Attractiveness to Clinical Programs & patient Access to Innovative Treatments”

The signing took place at the JFDA offices on Monday, May 15th 2023 and was signed by Mr. Samer S. Judeh, AmCham-Jordan’s Chairman, Dr. Muath Al-Zghool, LAWG Elected Chair, and H.E. Dr. Nizar Mhaidat, General Director of the Food and Drug Administration.

The MoU is a form of a mutual commitment between the private and public sectors to support and complete each other’s duties and function in the perspective of national healthcare development, through ensuring access to innovative treatments in Jordan.

The MoU coverage is focused on the fields of, among others, medical products safety, efficiency and quality, as well as improving patient and health care through partnering with local authorities to ensure equitable access to treatments.